Related Experiment Video
Updated: Apr 19, 2026

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Effects of the antibiotics Gentamicin on the postembryonic development of Chrysomya putoria (Diptera: Calliphoridae)
Adriana C P Ferraz1, Daniele L Dallavecchia2, Débora C Silva3
1Departamento de Microbiologia e Parasitologia, Laboratório de Estudo de Dípteros, Instituto Biomédico, Universidade Federal do Estado do Rio de Janeiro, UNIRIO, Rua Frei Caneca, 94, Centro, Cep 20211-040, Rio de Janeiro, RJ, Brasil Universidade Federal Rural do Rio de Janeiro, UFRRJ, Programa de Pós-Graduação em Biologia Animal PPGBA, Rod. BR 465, Km 7, CEP 23890-000 Seropédica, RJ, Brasil.
Abstract:
We evaluate the effects the antibiotic Gentamicin on the development of Chrysomya putoria (Wiedemann, 1818). Third-generation, first-instar larvae were reared in a climatic chamber on 60 g of homogenate + agar 65% and were treated with three concentrations of Gentamicin: 4.44 mg/ml, 13.33 mg/ml, and 66.66 mg/ml. The control consisted of distilled water. The relationships between mean body mass of mature larvae (measured after diet abandonment, in batches of five individuals), duration of larval and pupal stages, and overall duration of development were analyzed. The actual sex ratio was compared against the expected using the chi square. None of the parameters measured differed significantly among the four treatments, with one exception: when Gentamicin concentration was 13.33 mg/ml, larval viability differed significantly from the control. All larvae from all treatments were considered normal. We conclude that the antibiotic did not significantly alter the development of C. putoria (Wiedemann) (Diptera: Calliphoridae).
More Related Videos
13:00The Insect Galleria mellonella as a Powerful Infection Model to Investigate Bacterial Pathogenesis
Published on: December 11, 2012
06:19Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
Published on: October 11, 2024